<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="102382">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01721460</url>
  </required_header>
  <id_info>
    <org_study_id>2012-0400</org_study_id>
    <nct_id>NCT01721460</nct_id>
  </id_info>
  <brief_title>Effects of Dexmedetomidine on Activity in the Subthalamic Nucleus</brief_title>
  <official_title>Effects of Dexmedetomidine on Neuronal Activity in the Subthalamic Nucleus During Deep Brain Stimulation Electrode Implantation Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <authority>United States: Data and Safety Monitoring Board</authority>
    <authority>United States: Institutional Review Board</authority>
    <authority>United States: Federal Government</authority>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to find out whether dexmedetomidine changes brain cell
      activity in the subthalamic nucleus (STN).

      In order to find whether dexmedetomidine is optimal for sedation during Deep brain
      stimulation surgery, we will measure the electrical activity in the STN during Deep brain
      stimulation surgery, and measure how this activity is changed during administration of
      Dexmedetomidine. We hypothesize that dexmedetomidine does not change the firing rate and
      pattern in the STN.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in average firing rate and pattern in the STN</measure>
    <time_frame>20-35 minutes following drug administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will calculate the root mean square (RMS) of the electrical activity as a measure of the spiking rate of neurons in the vicinity of the electrode tip.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to achieve optimal sedation</measure>
    <time_frame>20-35 minutes following drug administration</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to recovery</measure>
    <time_frame>20-35 minutes following drug administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time it takes for the patient to become alert after drug administration is stopped.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to recovery of the neuronal activity</measure>
    <time_frame>20-35 minutes following drug administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>Only if the drug actually change the neuronal activity.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Parkinson's Disease</condition>
  <condition>Deep Brain Stimulation Surgery</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of dexmedetomidine during the Microelectrode recording part of STN electrode implantation surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine infusion will be started with a loading dose of 1 mcg/Kg over ten to 20 minutes followed by a maintenance infusion of 0.7 mcg/Kg/hr until stable sedation is achieved.</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled to undergo bilateral STN electrode implantation surgery with
             Micro-electrode recording for the treatment of Parkinson's disease.

        Exclusion Criteria:

          -  Hypersensitivity to dexmedetomidine

          -  Bradycardia: Sinus rhythm slower than 50 bpm

          -  Known or suspected obstructive sleep apnea

          -  Suspected difficult intubation

          -  Pregnancy

          -  Under 18 years of age or over 85 years of age

          -  Cognitive disability impairing understanding the experiment or signing the informed
             consent form
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aeyal Raz, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison, Department of anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aeyal Raz, MD, PhD</last_name>
    <phone>+16082636662</phone>
    <email>raz@wisc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Wisconsin - Madison, School of Medicine and Public Health</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Raz Aeyal, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Banks I Matthew, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joel Johnson, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Pearce, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Deborah Rusy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank Sasse, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karl Sillay, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 1, 2012</lastchanged_date>
  <firstreceived_date>October 30, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SubThalamic Nucleus</keyword>
  <keyword>Microelectrode recording</keyword>
  <keyword>Deep Brain Stimulation Electrode implantation</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
